Search Results - "Burge, M. E."

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

Authors: Burge, M. E. Smith, D. Topham, C. et al.

Source: British Journal of Cancer. 5/8/2006, Vol. 94 Issue 9, p1281-1286. 6p. 6 Charts.

Retrospective review of pemetrexed with or without platinum in malignant mesothelioma: The Australian‘Special Access Scheme’ experience.

Authors: Burge, M. E. Joshua, A. M. McNeil, C. M. et al.

Source: Asia Pacific Journal of Clinical Oncology. Mar2005, Vol. 1 Issue 1, p47-52. 6p. 4 Charts, 2 Graphs.